| Period Ending | Dec 30, 2011 | Sep 29, 2011 | Jun 30, 2011 | Mar 31, 2011 |
|---|
|
Total Revenue
|
435,170
|
417,433
|
407,169
|
384,293
| | Cost of Revenue | 217,412 | 205,874 | 198,435 | 192,763 | | |
Gross Profit
|
217,758
|
211,559
|
208,734
|
191,530
| |
|
Operating Expenses |
|
Research Development | 57,555 | 49,928 | 46,292 | 43,232 |
|
Selling General and Administrative | 115,103 | 114,750 | 100,647 | 94,679 |
|
Non Recurring | 513 | 647 | 361 | 767 |
|
Others | 15,875 | 13,786 | 9,867 | 9,177 |
|
|
|
Total Operating Expenses | 189,046 | 179,111 | 157,167 | 147,855 | | | |
Operating Income or Loss
|
28,712
|
32,448
|
51,567
|
43,675
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 1,430 | (3,988) | 6,563 | 339 |
|
Earnings Before Interest And Taxes | 34,521 | 33,249 | 61,548 | 46,777 |
|
Interest Expense | 3,431 | 3,364 | 1,350 | 496 |
|
Income Before Tax | 31,090 | 29,885 | 60,198 | 46,281 |
|
Income Tax Expense | 2,427 | 2,689 | 6,020 | 7,409 |
|
Minority Interest | 740 | 775 | (500) | 831 |
|
|
|
Net Income From Continuing Ops | 33,782 | 32,760 | 57,096 | 42,466 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
29,403
|
27,971
|
53,678
|
39,703
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
29,403
|
27,971
|
53,678
|
39,703
|
|